Signal from the log
Xsensio
7 M$ · Series A · Switzerland · Medtech
Société lausannoise qui développe un capteur cutané suivant en continu les biomarqueurs du liquide interstitiel, métabolites, ions, protéines et hormones. Elle vise d'abord la détection précoce des défaillances d'organe chez les patients hospitalisés à risque, en réanimation, en oncologie et après chirurgie.
Verified
Announced on , logged by the watch of 12 August 2026.
- Operation
- Funding round
- Announced amount
- 7 M$
- Stage
- Series A
- Country
- Switzerland
- Sector
- Medtech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by WI Harper , with Privilège Ventures , European Innovation Council
Provenance
Source longevity
Logged on 12 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.